 | • レポートコード：QYR2104Z1938 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、DNA損傷応答治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リンパルザ、タルゼンナ、ゼジュラ、ルブラカ）、用途別市場規模（卵巣がん、乳がん、膵臓がん、前立腺がん）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・DNA損傷応答治療薬の市場動向 ・企業の競争状況、市場シェア ・DNA損傷応答治療薬の種類別市場規模（リンパルザ、タルゼンナ、ゼジュラ、ルブラカ） ・DNA損傷応答治療薬の用途別市場規模（卵巣がん、乳がん、膵臓がん、前立腺がん） ・DNA損傷応答治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・DNA損傷応答治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・DNA損傷応答治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・DNA損傷応答治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・DNA損傷応答治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie Inc、AstraZeneca、Bayer、BeiGene、Clovis Oncology、Debiopharm、Eli Lilly and Company、GlaxoSmithKline、Merck、NMS Group SpA、Onxeo、Pfizer、Repare Therapeutics、Sierra Oncology、Zentalis Pharmaceuticals） ・結論 |
Market Analysis and Insights: Global DNA Damage Response Drugs Market
The global DNA Damage Response Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global DNA Damage Response Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global DNA Damage Response Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global DNA Damage Response Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global DNA Damage Response Drugs market.
Global DNA Damage Response Drugs Scope and Market Size
DNA Damage Response Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DNA Damage Response Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Lynparza
Talzenna
Zejula
Rubraca
Segment by Application
Ovarian Cancer
Breast Cancer
Pancreatic Cancer
Prostate Cancer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie Inc
AstraZeneca
Bayer
BeiGene
Clovis Oncology
Debiopharm
Eli Lilly and Company
GlaxoSmithKline
Merck
NMS Group SpA
Onxeo
Pfizer
Repare Therapeutics
Sierra Oncology
Zentalis Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Damage Response Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lynparza
1.2.3 Talzenna
1.2.4 Zejula
1.2.5 Rubraca
1.3 Market by Application
1.3.1 Global DNA Damage Response Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Pancreatic Cancer
1.3.5 Prostate Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global DNA Damage Response Drugs Market Perspective (2016-2027)
2.2 DNA Damage Response Drugs Growth Trends by Regions
2.2.1 DNA Damage Response Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 DNA Damage Response Drugs Historic Market Share by Regions (2016-2021)
2.2.3 DNA Damage Response Drugs Forecasted Market Size by Regions (2022-2027)
2.3 DNA Damage Response Drugs Industry Dynamic
2.3.1 DNA Damage Response Drugs Market Trends
2.3.2 DNA Damage Response Drugs Market Drivers
2.3.3 DNA Damage Response Drugs Market Challenges
2.3.4 DNA Damage Response Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA Damage Response Drugs Players by Revenue
3.1.1 Global Top DNA Damage Response Drugs Players by Revenue (2016-2021)
3.1.2 Global DNA Damage Response Drugs Revenue Market Share by Players (2016-2021)
3.2 Global DNA Damage Response Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by DNA Damage Response Drugs Revenue
3.4 Global DNA Damage Response Drugs Market Concentration Ratio
3.4.1 Global DNA Damage Response Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Damage Response Drugs Revenue in 2020
3.5 DNA Damage Response Drugs Key Players Head office and Area Served
3.6 Key Players DNA Damage Response Drugs Product Solution and Service
3.7 Date of Enter into DNA Damage Response Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Damage Response Drugs Breakdown Data by Type
4.1 Global DNA Damage Response Drugs Historic Market Size by Type (2016-2021)
4.2 Global DNA Damage Response Drugs Forecasted Market Size by Type (2022-2027)
5 DNA Damage Response Drugs Breakdown Data by Application
5.1 Global DNA Damage Response Drugs Historic Market Size by Application (2016-2021)
5.2 Global DNA Damage Response Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America DNA Damage Response Drugs Market Size (2016-2027)
6.2 North America DNA Damage Response Drugs Market Size by Type
6.2.1 North America DNA Damage Response Drugs Market Size by Type (2016-2021)
6.2.2 North America DNA Damage Response Drugs Market Size by Type (2022-2027)
6.2.3 North America DNA Damage Response Drugs Market Size by Type (2016-2027)
6.3 North America DNA Damage Response Drugs Market Size by Application
6.3.1 North America DNA Damage Response Drugs Market Size by Application (2016-2021)
6.3.2 North America DNA Damage Response Drugs Market Size by Application (2022-2027)
6.3.3 North America DNA Damage Response Drugs Market Size by Application (2016-2027)
6.4 North America DNA Damage Response Drugs Market Size by Country
6.4.1 North America DNA Damage Response Drugs Market Size by Country (2016-2021)
6.4.2 North America DNA Damage Response Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe DNA Damage Response Drugs Market Size (2016-2027)
7.2 Europe DNA Damage Response Drugs Market Size by Type
7.2.1 Europe DNA Damage Response Drugs Market Size by Type (2016-2021)
7.2.2 Europe DNA Damage Response Drugs Market Size by Type (2022-2027)
7.2.3 Europe DNA Damage Response Drugs Market Size by Type (2016-2027)
7.3 Europe DNA Damage Response Drugs Market Size by Application
7.3.1 Europe DNA Damage Response Drugs Market Size by Application (2016-2021)
7.3.2 Europe DNA Damage Response Drugs Market Size by Application (2022-2027)
7.3.3 Europe DNA Damage Response Drugs Market Size by Application (2016-2027)
7.4 Europe DNA Damage Response Drugs Market Size by Country
7.4.1 Europe DNA Damage Response Drugs Market Size by Country (2016-2021)
7.4.2 Europe DNA Damage Response Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific DNA Damage Response Drugs Market Size (2016-2027)
8.2 Asia-Pacific DNA Damage Response Drugs Market Size by Type
8.2.1 Asia-Pacific DNA Damage Response Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific DNA Damage Response Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific DNA Damage Response Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific DNA Damage Response Drugs Market Size by Application
8.3.1 Asia-Pacific DNA Damage Response Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific DNA Damage Response Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific DNA Damage Response Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific DNA Damage Response Drugs Market Size by Region
8.4.1 Asia-Pacific DNA Damage Response Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific DNA Damage Response Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America DNA Damage Response Drugs Market Size (2016-2027)
9.2 Latin America DNA Damage Response Drugs Market Size by Type
9.2.1 Latin America DNA Damage Response Drugs Market Size by Type (2016-2021)
9.2.2 Latin America DNA Damage Response Drugs Market Size by Type (2022-2027)
9.2.3 Latin America DNA Damage Response Drugs Market Size by Type (2016-2027)
9.3 Latin America DNA Damage Response Drugs Market Size by Application
9.3.1 Latin America DNA Damage Response Drugs Market Size by Application (2016-2021)
9.3.2 Latin America DNA Damage Response Drugs Market Size by Application (2022-2027)
9.3.3 Latin America DNA Damage Response Drugs Market Size by Application (2016-2027)
9.4 Latin America DNA Damage Response Drugs Market Size by Country
9.4.1 Latin America DNA Damage Response Drugs Market Size by Country (2016-2021)
9.4.2 Latin America DNA Damage Response Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA Damage Response Drugs Market Size (2016-2027)
10.2 Middle East & Africa DNA Damage Response Drugs Market Size by Type
10.2.1 Middle East & Africa DNA Damage Response Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa DNA Damage Response Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa DNA Damage Response Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa DNA Damage Response Drugs Market Size by Application
10.3.1 Middle East & Africa DNA Damage Response Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa DNA Damage Response Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa DNA Damage Response Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa DNA Damage Response Drugs Market Size by Country
10.4.1 Middle East & Africa DNA Damage Response Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa DNA Damage Response Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Details
11.1.2 AbbVie Inc Business Overview
11.1.3 AbbVie Inc DNA Damage Response Drugs Introduction
11.1.4 AbbVie Inc Revenue in DNA Damage Response Drugs Business (2016-2021)
11.1.5 AbbVie Inc Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca DNA Damage Response Drugs Introduction
11.2.4 AstraZeneca Revenue in DNA Damage Response Drugs Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer DNA Damage Response Drugs Introduction
11.3.4 Bayer Revenue in DNA Damage Response Drugs Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 BeiGene
11.4.1 BeiGene Company Details
11.4.2 BeiGene Business Overview
11.4.3 BeiGene DNA Damage Response Drugs Introduction
11.4.4 BeiGene Revenue in DNA Damage Response Drugs Business (2016-2021)
11.4.5 BeiGene Recent Development
11.5 Clovis Oncology
11.5.1 Clovis Oncology Company Details
11.5.2 Clovis Oncology Business Overview
11.5.3 Clovis Oncology DNA Damage Response Drugs Introduction
11.5.4 Clovis Oncology Revenue in DNA Damage Response Drugs Business (2016-2021)
11.5.5 Clovis Oncology Recent Development
11.6 Debiopharm
11.6.1 Debiopharm Company Details
11.6.2 Debiopharm Business Overview
11.6.3 Debiopharm DNA Damage Response Drugs Introduction
11.6.4 Debiopharm Revenue in DNA Damage Response Drugs Business (2016-2021)
11.6.5 Debiopharm Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company DNA Damage Response Drugs Introduction
11.7.4 Eli Lilly and Company Revenue in DNA Damage Response Drugs Business (2016-2021)
11.7.5 Eli Lilly and Company Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline DNA Damage Response Drugs Introduction
11.8.4 GlaxoSmithKline Revenue in DNA Damage Response Drugs Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck DNA Damage Response Drugs Introduction
11.9.4 Merck Revenue in DNA Damage Response Drugs Business (2016-2021)
11.9.5 Merck Recent Development
11.10 NMS Group SpA
11.10.1 NMS Group SpA Company Details
11.10.2 NMS Group SpA Business Overview
11.10.3 NMS Group SpA DNA Damage Response Drugs Introduction
11.10.4 NMS Group SpA Revenue in DNA Damage Response Drugs Business (2016-2021)
11.10.5 NMS Group SpA Recent Development
11.11 Onxeo
11.11.1 Onxeo Company Details
11.11.2 Onxeo Business Overview
11.11.3 Onxeo DNA Damage Response Drugs Introduction
11.11.4 Onxeo Revenue in DNA Damage Response Drugs Business (2016-2021)
11.11.5 Onxeo Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer DNA Damage Response Drugs Introduction
11.12.4 Pfizer Revenue in DNA Damage Response Drugs Business (2016-2021)
11.12.5 Pfizer Recent Development
11.13 Repare Therapeutics
11.13.1 Repare Therapeutics Company Details
11.13.2 Repare Therapeutics Business Overview
11.13.3 Repare Therapeutics DNA Damage Response Drugs Introduction
11.13.4 Repare Therapeutics Revenue in DNA Damage Response Drugs Business (2016-2021)
11.13.5 Repare Therapeutics Recent Development
11.14 Sierra Oncology
11.14.1 Sierra Oncology Company Details
11.14.2 Sierra Oncology Business Overview
11.14.3 Sierra Oncology DNA Damage Response Drugs Introduction
11.14.4 Sierra Oncology Revenue in DNA Damage Response Drugs Business (2016-2021)
11.14.5 Sierra Oncology Recent Development
11.15 Zentalis Pharmaceuticals
11.15.1 Zentalis Pharmaceuticals Company Details
11.15.2 Zentalis Pharmaceuticals Business Overview
11.15.3 Zentalis Pharmaceuticals DNA Damage Response Drugs Introduction
11.15.4 Zentalis Pharmaceuticals Revenue in DNA Damage Response Drugs Business (2016-2021)
11.15.5 Zentalis Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global DNA Damage Response Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Lynparza
Table 3. Key Players of Talzenna
Table 4. Key Players of Zejula
Table 5. Key Players of Rubraca
Table 6. Global DNA Damage Response Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global DNA Damage Response Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global DNA Damage Response Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global DNA Damage Response Drugs Market Share by Regions (2016-2021)
Table 10. Global DNA Damage Response Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global DNA Damage Response Drugs Market Share by Regions (2022-2027)
Table 12. DNA Damage Response Drugs Market Trends
Table 13. DNA Damage Response Drugs Market Drivers
Table 14. DNA Damage Response Drugs Market Challenges
Table 15. DNA Damage Response Drugs Market Restraints
Table 16. Global DNA Damage Response Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global DNA Damage Response Drugs Market Share by Players (2016-2021)
Table 18. Global Top DNA Damage Response Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Damage Response Drugs as of 2020)
Table 19. Ranking of Global Top DNA Damage Response Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by DNA Damage Response Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players DNA Damage Response Drugs Product Solution and Service
Table 23. Date of Enter into DNA Damage Response Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global DNA Damage Response Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global DNA Damage Response Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global DNA Damage Response Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global DNA Damage Response Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global DNA Damage Response Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global DNA Damage Response Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global DNA Damage Response Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America DNA Damage Response Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America DNA Damage Response Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America DNA Damage Response Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America DNA Damage Response Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America DNA Damage Response Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe DNA Damage Response Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe DNA Damage Response Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe DNA Damage Response Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe DNA Damage Response Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe DNA Damage Response Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific DNA Damage Response Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific DNA Damage Response Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific DNA Damage Response Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific DNA Damage Response Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific DNA Damage Response Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America DNA Damage Response Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America DNA Damage Response Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America DNA Damage Response Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America DNA Damage Response Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America DNA Damage Response Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa DNA Damage Response Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa DNA Damage Response Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa DNA Damage Response Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa DNA Damage Response Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa DNA Damage Response Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa DNA Damage Response Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Inc Company Details
Table 64. AbbVie Inc Business Overview
Table 65. AbbVie Inc DNA Damage Response Drugs Product
Table 66. AbbVie Inc Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 67. AbbVie Inc Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca DNA Damage Response Drugs Product
Table 71. AstraZeneca Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Bayer Company Details
Table 74. Bayer Business Overview
Table 75. Bayer DNA Damage Response Drugs Product
Table 76. Bayer Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 77. Bayer Recent Development
Table 78. BeiGene Company Details
Table 79. BeiGene Business Overview
Table 80. BeiGene DNA Damage Response Drugs Product
Table 81. BeiGene Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 82. BeiGene Recent Development
Table 83. Clovis Oncology Company Details
Table 84. Clovis Oncology Business Overview
Table 85. Clovis Oncology DNA Damage Response Drugs Product
Table 86. Clovis Oncology Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 87. Clovis Oncology Recent Development
Table 88. Debiopharm Company Details
Table 89. Debiopharm Business Overview
Table 90. Debiopharm DNA Damage Response Drugs Product
Table 91. Debiopharm Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 92. Debiopharm Recent Development
Table 93. Eli Lilly and Company Company Details
Table 94. Eli Lilly and Company Business Overview
Table 95. Eli Lilly and Company DNA Damage Response Drugs Product
Table 96. Eli Lilly and Company Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 97. Eli Lilly and Company Recent Development
Table 98. GlaxoSmithKline Company Details
Table 99. GlaxoSmithKline Business Overview
Table 100. GlaxoSmithKline Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 101. GlaxoSmithKline Recent Development
Table 102. Merck Company Details
Table 103. Merck Business Overview
Table 104. Merck DNA Damage Response Drugs Product
Table 105. Merck Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 106. Merck Recent Development
Table 107. NMS Group SpA Company Details
Table 108. NMS Group SpA Business Overview
Table 109. NMS Group SpA DNA Damage Response Drugs Product
Table 110. NMS Group SpA Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 111. NMS Group SpA Recent Development
Table 112. Onxeo Company Details
Table 113. Onxeo Business Overview
Table 114. Onxeo DNA Damage Response Drugs Product
Table 115. Onxeo Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 116. Onxeo Recent Development
Table 117. Pfizer Company Details
Table 118. Pfizer Business Overview
Table 119. Pfizer DNA Damage Response Drugs Product
Table 120. Pfizer Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 121. Pfizer Recent Development
Table 122. Repare Therapeutics Company Details
Table 123. Repare Therapeutics Business Overview
Table 124. Repare Therapeutics DNA Damage Response Drugs Product
Table 125. Repare Therapeutics Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 126. Repare Therapeutics Recent Development
Table 127. Sierra Oncology Company Details
Table 128. Sierra Oncology Business Overview
Table 129. Sierra Oncology DNA Damage Response Drugs Product
Table 130. Sierra Oncology Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 131. Sierra Oncology Recent Development
Table 132. Zentalis Pharmaceuticals Company Details
Table 133. Zentalis Pharmaceuticals Business Overview
Table 134. Zentalis Pharmaceuticals DNA Damage Response Drugs Product
Table 135. Zentalis Pharmaceuticals Revenue in DNA Damage Response Drugs Business (2016-2021) & (US$ Million)
Table 136. Zentalis Pharmaceuticals Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global DNA Damage Response Drugs Market Share by Type: 2020 VS 2027
Figure 2. Lynparza Features
Figure 3. Talzenna Features
Figure 4. Zejula Features
Figure 5. Rubraca Features
Figure 6. Global DNA Damage Response Drugs Market Share by Application: 2020 VS 2027
Figure 7. Ovarian Cancer Case Studies
Figure 8. Breast Cancer Case Studies
Figure 9. Pancreatic Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. DNA Damage Response Drugs Report Years Considered
Figure 12. Global DNA Damage Response Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global DNA Damage Response Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global DNA Damage Response Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global DNA Damage Response Drugs Market Share by Regions (2022-2027)
Figure 16. Global DNA Damage Response Drugs Market Share by Players in 2020
Figure 17. Global Top DNA Damage Response Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Damage Response Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by DNA Damage Response Drugs Revenue in 2020
Figure 19. Global DNA Damage Response Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global DNA Damage Response Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America DNA Damage Response Drugs Market Share by Type (2016-2027)
Figure 23. North America DNA Damage Response Drugs Market Share by Application (2016-2027)
Figure 24. North America DNA Damage Response Drugs Market Share by Country (2016-2027)
Figure 25. United States DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe DNA Damage Response Drugs Market Share by Type (2016-2027)
Figure 29. Europe DNA Damage Response Drugs Market Share by Application (2016-2027)
Figure 30. Europe DNA Damage Response Drugs Market Share by Country (2016-2027)
Figure 31. Germany DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific DNA Damage Response Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific DNA Damage Response Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific DNA Damage Response Drugs Market Share by Region (2016-2027)
Figure 41. China DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America DNA Damage Response Drugs Market Share by Type (2016-2027)
Figure 49. Latin America DNA Damage Response Drugs Market Share by Application (2016-2027)
Figure 50. Latin America DNA Damage Response Drugs Market Share by Country (2016-2027)
Figure 51. Mexico DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa DNA Damage Response Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa DNA Damage Response Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa DNA Damage Response Drugs Market Share by Country (2016-2027)
Figure 57. Turkey DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE DNA Damage Response Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AbbVie Inc Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 63. BeiGene Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 64. Clovis Oncology Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 65. Debiopharm Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 66. Eli Lilly and Company Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 68. Merck Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 69. NMS Group SpA Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 70. Onxeo Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 72. Repare Therapeutics Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 73. Sierra Oncology Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 74. Zentalis Pharmaceuticals Revenue Growth Rate in DNA Damage Response Drugs Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の膵臓がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Drugs Market The global Pancreatic Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…- 世界の乳がん用ジェネリック医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Generic Drugs Market The global Breast Cancer Generic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の乳がん用ジェネリック医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Generic Drugs Market The global Breast Cancer Generic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の膵臓がん治療薬市場 2021：企業別、地域別、種類・用途別 The Pancreatic Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…